Acupuncture for moderate to severe eczema
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This trial tests whether acupuncture can help people with moderate-to-severe atopic dermatitis (eczema) feel less itchy. If you have persistent itch and are between 18 and 75 years old, you may qualify.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with moderate to severe atopic dermatitis (eczema).
- You are between 18 and 75 years old.
- Your worst itch in the last 24 hours is at least a 4 out of 10 on a standard rating scale.
- You are willing to try acupuncture and not currently using certain medications for eczema.
- You are not pregnant or breastfeeding, and you have not had acupuncture before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an injected medicine called XKH001 for adults with moderate to severe eczema that hasn't been helped enough by creams. It aims to see if it can reduce itching and skin symptoms.
This trial tests a new stem cell injection called ADSTEM for people with moderate to severe eczema that hasn't improved with standard treatments. The goal is to see if it can reduce eczema symptoms like itching, redness, and skin rash.
This trial tests an experimental drug called EC-18 (a pill) for people with moderate to severe eczema that hasn't been controlled well with creams. It aims to see if different doses of the drug can safely reduce itching and skin rash.
This trial tests a new drug called IBI3002 in people with moderate-to-severe atopic dermatitis (eczema) to see if it is safe and tolerable. It may help reduce skin inflammation and itching.
This study tests a new medication called IBI3002 for people with moderate to severe eczema (atopic dermatitis) that hasn't been well controlled by standard creams. The goal is to see if IBI3002 can reduce skin inflammation and itching.
This trial tests an oral medication called ICP-332 for adults with moderate to severe eczema (atopic dermatitis) who haven't gotten enough relief from topical creams. It aims to see if the drug can reduce skin inflammation and itching.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.